Long-acting Repeatable Octreotide Acetate for Injectable Suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Long-acting Repeatable Octreotide Acetate for Injectable Suspension, covering 2012-04-11 to 2012-04-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly [Phase 3]